Literature DB >> 17925800

Can fibroblast growth factor 23 fine-tune therapies for diseases of abnormal mineral ion metabolism?

M Shawkat Razzaque1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17925800     DOI: 10.1038/ncpendmet0667

Source DB:  PubMed          Journal:  Nat Clin Pract Endocrinol Metab        ISSN: 1745-8366


× No keyword cloud information.
  11 in total

1.  Therapeutic potential of klotho-FGF23 fusion polypeptides: WO2009095372.

Authors:  Mohammed S Razzaque
Journal:  Expert Opin Ther Pat       Date:  2010-07       Impact factor: 6.674

Review 2.  Does FGF23 toxicity influence the outcome of chronic kidney disease?

Authors:  Mohammed Shawkat Razzaque
Journal:  Nephrol Dial Transplant       Date:  2008-11-07       Impact factor: 5.992

3.  FGF23-induced hypophosphatemia persists in Hyp mice deficient in the WNT coreceptor Lrp6.

Authors:  Kazuyoshi Uchihashi; Teruyo Nakatani; Regina Goetz; Moosa Mohammadi; Xi He; Mohammed S Razzaque
Journal:  Contrib Nephrol       Date:  2013-05-03       Impact factor: 1.580

4.  Molecular regulation of phosphate metabolism by fibroblast growth factor-23-klotho system.

Authors:  Chung-Yi Cheng; Makoto Kuro-o; Mohammed S Razzaque
Journal:  Adv Chronic Kidney Dis       Date:  2011-03       Impact factor: 3.620

Review 5.  The FGF23-Klotho axis: endocrine regulation of phosphate homeostasis.

Authors:  M Shawkat Razzaque
Journal:  Nat Rev Endocrinol       Date:  2009-11       Impact factor: 43.330

Review 6.  Does Fgf23-klotho activity influence vascular and soft tissue calcification through regulating mineral ion metabolism?

Authors:  Fahad Memon; Mohga El-Abbadi; Teruyo Nakatani; Takashi Taguchi; Beate Lanske; M Shawkat Razzaque
Journal:  Kidney Int       Date:  2008-06-04       Impact factor: 10.612

7.  Reversal of mineral ion homeostasis and soft-tissue calcification of klotho knockout mice by deletion of vitamin D 1alpha-hydroxylase.

Authors:  Mutsuko Ohnishi; Teruyo Nakatani; Beate Lanske; M Shawkat Razzaque
Journal:  Kidney Int       Date:  2009-02-18       Impact factor: 10.612

8.  In vivo genetic evidence for klotho-dependent, fibroblast growth factor 23 (Fgf23) -mediated regulation of systemic phosphate homeostasis.

Authors:  Teruyo Nakatani; Bara Sarraj; Mutsuko Ohnishi; Michael J Densmore; Takashi Taguchi; Regina Goetz; Moosa Mohammadi; Beate Lanske; M Shawkat Razzaque
Journal:  FASEB J       Date:  2008-10-03       Impact factor: 5.191

Review 9.  FGF23-mediated regulation of systemic phosphate homeostasis: is Klotho an essential player?

Authors:  M Shawkat Razzaque
Journal:  Am J Physiol Renal Physiol       Date:  2008-11-19

10.  Inactivation of klotho function induces hyperphosphatemia even in presence of high serum fibroblast growth factor 23 levels in a genetically engineered hypophosphatemic (Hyp) mouse model.

Authors:  Teruyo Nakatani; Mutsuko Ohnishi; M Shawkat Razzaque
Journal:  FASEB J       Date:  2009-07-07       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.